Ifebemtinib

• Description:

  Ifebemtinib (BI-853520) is an orally active and potent inhibitor of adhesion plaque kinase (FAK) (IC50=1 nM) with anti-tumour activity that inhibits globule formation and in situ tumour growth in malignant pleural mesotheliomas, and may be useful for the study of breast and ovarian cancer.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  588.55

• Molecular Formula:

  C28H28F4N6O4

• Notes:

  Research use only, not for human use.

• Receptor:

  FAK

• CAS Number:

  1227948-82-4